Credit Suisse First Boston is advising Zimmer, the US orthopaedics company, on a Sfr4.16bn (€2.75bn) offer for Swiss rival Centerpulse, giving the bank's healthcare team its second transatlantic deal in two days.
On Monday CSFB advised PowderJect Pharmaceuticals in the UK on its proposed £542m (€759m) takeover by Chiron, the US pharmaceuticals company. A spokesman for Zimmer confirmed that CSFB, which is not a retained adviser to the company, was hired to advise on the Centerpulse deal because of the strength of its healthcare team.
